Tags: cancer | cervical | tivdak | pfizer | fda | approval

FDA Approved Pfizer's Cervical Cancer Drug

microscopic view of cervical cancer cells
(Dreamstime)

Tuesday, 30 April 2024 07:14 AM EDT

The U.S. Food and Drug Administration (FDA) granted full approval for Pfizer's drug for treating cervical cancer patients whose disease had progressed on or after chemotherapy, the agency said on Monday.

The treatment, Tivdak - an antibody-drug conjugate co-developed by Genmab A/S and Seagen - received the FDA's accelerated approval for the same indication in 2021.

It was added to Pfizer's oncology portfolio last year through a $43 billion deal to acquire Seagen, along with other targeted cancer therapies.

The health regulator's full approval was based on data from a late-stage trial that enrolled 502 patients. It tested Tivdak versus investigators' choice of chemotherapy in patients with cervical cancer.

Tivdak in the trial demonstrated a 30% reduction in the risk of death in patients, compared with chemotherapy. 

© 2024 Thomson/Reuters. All rights reserved.


Health-News
The U.S. Food and Drug Administration (FDA) granted full approval for Pfizer's drug for treating cervical cancer patients whose disease had progressed on or after chemotherapy, the agency said on Monday. The treatment, Tivdak - an antibody-drug conjugate co-developed by...
cancer, cervical, tivdak, pfizer, fda, approval
127
2024-14-30
Tuesday, 30 April 2024 07:14 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Find Your Condition
Get Newsmax Text Alerts
TOP

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved